Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-24 Sale |
2020-12-29 4:01 pm |
Fusion Pharmaceuticals Inc. | FUSN | ADAMS STREET PARTNERS LLC 10% Owner |
3,800 | $12.32 | $46,816 | 1,457,115 (Indirect) |
View |
| 2020-12-23 Sale |
2020-12-28 4:02 pm |
Fusion Pharmaceuticals Inc. | FUSN | ADAMS STREET PARTNERS LLC 10% Owner |
4,569 | $12.39 | $56,610 | 1,458,699 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-04 Option Award |
2021-06-07 4:15 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:14 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:13 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:12 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | Bergstrom Donald A Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-01 4:20 pm |
N/A 2031-04-01 |
Fusion Pharmaceuticals Inc. | FUSN | Bergstrom Donald A Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-12 5:42 pm |
N/A 2031-02-10 |
Fusion Pharmaceuticals Inc. | FUSN | Lee Philina Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 9:27 pm |
N/A 2031-02-03 |
Fusion Pharmaceuticals Inc. | FUSN | Crowley John J Chief Financial Officer |
138,000 | $0 | 138,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 9:10 pm |
N/A 2031-02-03 |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
336,000 | $0 | 336,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 9:05 pm |
N/A 2031-02-03 |
Fusion Pharmaceuticals Inc. | FUSN | Burak Eric Chief Scientific Officer |
316,600 | $0 | 316,600 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 9:01 pm |
N/A 2031-02-03 |
Fusion Pharmaceuticals Inc. | FUSN | O'Leary James J Chief Medical Officer |
114,000 | $0 | 114,000 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:56 pm |
N/A 2030-10-29 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
30,000 | $0 | 30,000 (Direct) |
View |